Sintx Technologies (SINT) Change in Accured Expenses (2013 - 2026)
Sintx Technologies (SINT) recorded quarterly Change in Accured Expenses of $659000.0 in Q1 2026, up 247.43% quarter-over-quarter from -$447000.0 in Q4 2025, and up 14.41% on a YoY basis from $576000.0 in Q1 2025.
Sintx Technologies (SINT) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Sintx Technologies' Change in Accured Expenses history runs 14 years deep, the most recent figure standing at $659000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 14.41% year-over-year to $659000.0; the TTM figure through Mar 2026 stood at -$117000.0 (down 126.23% YoY), while the FY2025 annual figure was -$200000.0, down 9900.0% from the prior year.
- Change in Accured Expenses was $659000.0 for Q1 2026 at Sintx Technologies, up from -$447000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $659000.0 in Q1 2026 to a low of -$537000.0 in Q3 2025.
- Historically, Change in Accured Expenses has averaged $19812.5 across 5 years, with a median of $1000.0 in 2022.
- Biggest YoY gain for Change in Accured Expenses was 22900.0% in 2023; the steepest drop was 11333.33% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at -$96000.0 in 2022, then plunged by 95.83% to -$188000.0 in 2023, then soared by 179.79% to $150000.0 in 2024, then tumbled by 398.0% to -$447000.0 in 2025, then surged by 247.43% to $659000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $659000.0 (Q1 2026), -$447000.0 (Q4 2025), and -$537000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Sintx Technologies | 8.59 Mn | 6.70 Mn | 144,000.00 | 659,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 659,000.00 |
| Mar 31, 2026 | 659,000.00 |
| Dec 31, 2025 | -447,000.00 |
| Dec 31, 2025 | -447,000.00 |
| Sep 30, 2025 | -537,000.00 |
| Sep 30, 2025 | -537,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | -188,000.00 |
| Dec 31, 2023 | -188,000.00 |
| Sep 30, 2023 | 285,000.00 |
| Sep 30, 2023 | 285,000.00 |